Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Asian Pacific Journal of Cancer Prevention : APJCP|May 29, 2012
Genetic variants of NBS1 predict clinical outcome of platinum-based chemotherapy in advanced non-small cell lung cancer in ChineseJia-Li Xu, Ling-Min Hu, Ming-De Huang, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|April 25, 2012
Association between the Ku70-1310C/G promoter polymorphism and cancer risk: a meta-analysisLu Xu, Xiao-Bing Ju, Pu Li, et al.
Biomaterials|December 25, 2009
The effects of mixed MPEG-PLA/Pluronic copolymer micelles on the bioavailability and multidrug resistance of docetaxelChao-Feng Mu, Prabagar Balakrishnan, Fu-De Cui, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 29, 2012
MLH1 polymorphisms and cancer risk: a meta-analysis based on 33 case-control studiesJia-Li Xu, Zhi-Qiang Yin, Ming-De Huang, et al.
Acta Pharmacologica Sinica|February 15, 2024
Quantitative systems pharmacology modeling of HER2-positive metastatic breast cancer for translational efficacy evaluation and combination assessment across therapeutic modalitiesYa-Ting Zhou, Jia-Hui Chu, Shu-Han Zhao, et al.
The American Journal of Surgical Pathology|August 15, 2022
GLI1 -Rearranged Enteric Tumor : Expanding the Spectrum of Gastrointestinal Neoplasms With GLI1 Gene FusionsJosé Jessurun, Christine Orr, Samantha N McNulty, et al.
The Lancet. Oncology|March 22, 2015
Cisplatin plus gemcitabine versus paclitaxel plus gemcitabine as first-line therapy for metastatic triple-negative breast cancer (CBCSG006): a randomised, open-label, multicentre, phase 3 trialXi-Chun Hu, Jian Zhang, Bing-He Xu, et al.
Therapeutic Advances in Medical Oncology|November 5, 2020
MONARCH plus: abemaciclib plus endocrine therapy in women with HR+/HER2- advanced breast cancer: the multinational randomized phase III studyQing Yuan Zhang, Tao Sun, Yong Mei Yin, et al.
Annals of Translational Medicine|August 29, 2022
Age at initial diagnosis and prognosis of breast cancer: a nationwide multicenter retrospective study in ChinaHuan Yang, Qu-Chang Ouyang, Min Yan, et al.
Frontiers in Oncology|February 10, 2023
Molecular subtypes predict the preferential site of distant metastasis in advanced breast cancer: a nationwide retrospective studyJin-Hu Fan, Su Zhang, Huan Yang, et al.
Pageof 4